Phase I Study of a Recombinant Adenovirus-Mediated Gene Transfer in Lung Cancer Patients

Abstract

This ongoing phase I study has demonstrated that a recombinant adenovirus-mediated marker gene, such as rAd.RSV beta-gal, can be safely introduced into humans and that the gene product is expressed by lung tumor cells of the host.